Hannover Rück (HNR1) Q3 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2025 earnings summary
10 Nov, 2025Executive summary
Group net income for the first nine months reached EUR 1,964.8 million, up 7.7% year-over-year, with return on equity at 22.0%.
Net income guidance for the full year 2025 was raised to EUR 2.6 billion, reflecting strong business performance and prudent loss realization in fixed income.
Shareholders' equity increased by up to 2% over nine months, driven by strong earnings despite negative currency effects.
Additional profits were used to strengthen the balance sheet, increase P&C reserves, and realize over EUR 300 million in fixed income losses to improve future returns.
One-off positive tax effect from German corporate tax reform contributed to a lower tax ratio and deferred tax liabilities.
Financial highlights
Adjusted P&C revenue growth was close to 10% year-over-year, ahead of the 7% target; reinsurance revenue reached EUR 19,711 million, up 2.1% currency-adjusted.
Combined ratio for P&C improved to 86.0%, in line with or better than targets.
Life & Health reinsurance revenue grew moderately, with new business CSM up to EUR 575 million and strong new business generation.
Reinsurance service result reached EUR 671 million, supporting full-year targets.
Return on investment was 2.8%, below target due to deliberate loss realization in fixed income.
Solvency ratio remained strong at 259%.
Outlook and guidance
Net income target for 2025 increased to EUR 2.6 billion, with 2026 guidance set at least EUR 2.7 billion.
Combined ratio for 2025 and 2026 expected below 87%; ROI target set at 2.9% for 2025 and 3.5% for 2026.
P&C revenue growth expected to exceed 7% in 2025; Life & Health reinsurance service result targeted above EUR 875 million in 2025 and around EUR 925 million in 2026.
New dividend policy: regular payout ratio raised to ~55% of IFRS net income.
Latest events from Hannover Rück
- Net income up 13.4%, dividend rises nearly 40%, and 2026 guidance signals continued growth.HNR1
Q4 202512 Mar 2026 - Net income up 20.9% to €1.16bn, with strong P&C growth and robust capital position.HNR1
Q2 20241 Feb 2026 - Raised 2025 net income guidance to ~€2.6bn, with 21.2% ROE and strong capitalisation.HNR1
Company presentation26 Jan 2026 - Net income rose 30.4% to €1.82bn, raising 2024 guidance to €2.3bn on strong P&C results.HNR1
Q3 202415 Jan 2026 - 2025 guidance reaffirmed despite LA wildfire losses, with strong premium growth and disciplined renewals.HNR1
Status Update8 Jan 2026 - Net income up 27.6% to EUR 2,329m, dividend up 25%, and solvency ratio at 261%.HNR1
Q4 20242 Dec 2025 - Net income up 13.2% to EUR 1.3 billion, with strong growth and robust capital position.HNR1
Q2 202523 Nov 2025 - Net income dropped 13.9% on wildfire losses, but guidance and capital strength remain solid.HNR1
Q1 202518 Nov 2025 - Exceeding growth targets with a 55% payout ratio and strong, diversified expansion.HNR1
CMD 20259 Oct 2025